Skip to main content
Erschienen in: BMC Gastroenterology 1/2019

Open Access 01.12.2019 | Case report

Lupus enteritis masquerading as Crohn’s disease

verfasst von: Xiu-Li Zhu, Xue-Mei Xu, Si Chen, Qiao-Min Wang, Kai-Guang Zhang

Erschienen in: BMC Gastroenterology | Ausgabe 1/2019

Abstract

Background

Systemic lupus erythematosus is an autoimmune disease which can affect multiple organs, resulting in significant mortality and morbidity. Lupus enteritis is one of the rare complications of SLE, defined as vasculitis of the intestinal tract, with supportive biopsy findings and/or image. However, lupus enteritis is seldom confirmed on histology or image and the changes of intestinal mucosa are nonspecific. Crohn’s disease is a chronic inflammatory disorder of the gastrointestinal tract which affects any part of the gastrointestinal tract. The diagnosis of CD is confirmed by clinical evaluation and a combination of endoscopic, histology, radiology, and/or biochemical investigations.

Case presentation

Here we report a rare case of a 71-years-old Chinese male has been diagnosed with lupus enteritis which similar to CD in the aspects of endoscopic, histology, and radiology. So far, there are no relevant cases reported.

Conclusions

The endoscopic appearance of lupus enteritis is nonspecific, on the basis of our case, the features of lupus enteritis can be described as spacious, clean and no moss ulcers which discontinuous involved all gastrointestinal tract.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CD
Crohn’s disease
CRP
C-reactive protein
CT
Computed tomography
ESR
Erythrocyte sedimentation rate
SLE
Systemic lupus erythematosus

Background

Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disorder in which the body’s immune system mistakenly attacks healthy tissue. The disease is gender-related occurring nine times more likely in women than men, especially in women of child-bearing years (15 to 35 years old) [1]. SLE usually damages the heart, joints, skin, lungs, blood vessels, kidneys, and nervous system. In recent years, some studies have reported that SLE also harms gastrointestinal tract and lupus enteritis as an initial manifestation of SLE. There is no standard definition of lupus enteritis, most scholars believe that lupus enteritis is vasculitis or intestinal inflammation with supportive images and/or biopsy results. But it is so difficult to diagnose lupus enteritis relying on histology and radiology in the clinic. Crohn’s disease (CD) is a lifelong disease caused by the interaction between infectious, immune, genetic and environmental factors. A single gold standard for the diagnosis of CD is not available. The current view is that diagnosis is based on a combination of clinical manifestations, endoscopic appearance, radiology, histology, and surgical outcomes, however, this still results in diagnostic obstacles [2]. The two diseases are rare and the diagnosis is difficult. The following case describe an old male presenting with lupus enteritis and diarrhea as the initial manifestation of SLE, but in terms of endoscopy, histology, and radiology, the case is similar to CD. To the best of our knowledge, there are no relevant cases reported in the English literature.

Case presentation

A 71-year-old Chinese male with no significant medical history was admitted to the department of gastroenterology in our hospital with three months of watery diarrhea and mild abdominal pain. The patient described the diarrhea frequency was six to ten times per day without mucoid or blood. Physical examination revealed one oral ulcer, tenderness of the abdomen without rebound tenderness and shifting dullness. Laboratory tests revealed a leukocyte count of 12.5*109/L, anemia (hemoglobin of 67 g/L) and a positive antinuclear antibody titer of 1:3200, positive serology for the antiphospholipid antibody. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were 130 mm/h and 117 mg/L, respectively (normal: 0-15 mm/h and 0–8 mg/l, respectively). Complement components C3 and C4 were 50 mg/dL and 12 mg/dL, respectively (normal: 86-160 mg/dL and 17-45 mg/dL, respectively). Syphilis serology and TPPA/TPHA, TRUST were positive. PPD experiment and T-spot test were negative. Fecal routine, fecal bacteriological tests (C.difficile, Salmonella, Campylobacter, Yersinia and many more) and fecal virological tests were all normal. Contrast-enhanced computed tomography (CT) of the chest and abdomen revealed polyserositis (pleural effusion, ascites, pericardial effusion) and marked thickening of the entire colonic mucosa (Fig. 1). Ascites routine revealed pale yellow and Rivalta test(+), quantitative counting of nucleated cells were 462*106/L and monocytes (72%), coenocyte (27.7%). Electronic colonoscopy showed multiple ulcers in the terminal ileum and colon which were circular, wide, clean, without moss and hyperplastic lesions around the anus (Fig. 2). The pathology tended to CD because there were ganglion cell and crack shape ulcer (Fig. 3). Gastroscopy showed no obvious abnormalities in another hospital.
Through the case discussion in the multi-disciplinary team (MDT) including histology, radiology, rheumatology, and gastroenterology we diagnosed the patient with lupus enteritis prior to CD. Then the patient was given systemic steroids (Solu-Medrol 80 mg QD) and within a few days (7–10 days) the abdominal pain and diarrhea began to resolve. The patient was discharged on a tapering dose of steroids (Prednisone 50 mg QD). The CRP, ESR, Complement components C3 and C4 were normal after two months.
However, the patient complained of bloating after a meal three months after discharge, gastroscopy combined with angiography showed there was gastric-intestinal fistula (Fig. 4). Electronic colonoscopy showed no significant improvement compared with the previous, intestinal ulcer surface covered with white moss (Fig. 5). The patient had severe abdominal pain soon, we considered there was digestive tract perforation and recommended surgery, his family members refused further treatment due to economic reasons and he died after one day.

Discussion and conclusions

The American College of Rheumatology (ACR) established eleven criteria in 1982, which were revised in 1997 as a classification tool for implementing SLE definitions in clinical trials [3]. If a person has any 4 out of 11 symptoms, he is with SLE. In our case, the old male meets five criteria: (1) oral ulcer; (2) polyserositis including pleural effusion, ascites and, pericardial effusion; (3)anemia; (4) positive serology for antiphospholipid antibody and syphilis; (5) positive antinuclear antibody titer of 1:3200. From the above, the patient with SLE is clear. The multiple intestinal ulcers need differential diagnosis between CD and lupus enteritis. CD is a chronic and disabling inflammatory disease of the digestive system of unknown etiology. The incidence of CD is highest in the Northern Europe, more and more young people have been diagnosed CD in China recently [4]. The diagnosis of CD is established by a combination of clinical symptoms, endoscopic appearance, radiology and histology. Chronic diarrhea is the most common symptom in CD. The most significant endoscopic features of CD are discontinuous involvement, anal lesions, and cobble stoning. CT is an imaging technique with the highest diagnostic accuracy for the detection of intestinal involvement and penetrating lesions in CD, the features of CD are dilation, tortuosity, prominence and wide spacing of mesentery with mesenteric arterial which called comb’s sign [5]. Focal crypt irregularity and granulomas are the generally accepted pathological features. There are some aspects support CD: (1) chronic diarrhea; (2) marked thickening of the entire colonic mucosa; (3) pathological tend to CD. However, there are some opposed points: (1) old male and short disease course; (3) endoscopic appearance is not totally conformed to CD. There is no consistent definition of lupus enteritis. Some scholars believe that lupus enteritis is the basis of a series of processes, including intestinal vasculitis, mesenteric arteritis, abdominal serositis and lupus peritonitis [6]. Most people think that lupus enteritis is vasculitis or inflammation of the intestinal tract. The most frequent symptoms were abdominal pain and diarrhea. CT and pathology have become the gold standard for diagnosis [7]. Typical features include bowel dilation,bowel-wall thickening, abnormal bowel wall enhancement (target sign) [8], engorgement of mesenteric vessels with an increased number of visible vessels (comb’s sign). These are nonspecific because the above-described abnormalities can also be seen in patients with pancreatitis, peritonitis or CD. There is no unified view about the endoscopic appearance of lupus enteritis, only one Chinese professor described “deep ulcer” in a case report of lupus enteritis. In our case, the ulcers of the terminal ileum and colon are similar to CD and “deep ulcer” in a few points. On the basis of diagnosis in patients with SLE, the endoscopic appearance was more inclined to lupus enteritis and treatment effect also confirmed this point. Whether SLE can cause gastrointestinal perforation nor not, less reported at present. Oshimo Y [9] reported a case of the elderly man with SLE associated with paralytic ileus and fistula formation in 1999, our case is the first case of SLE with gastric-intestinal fistula.
The differentiation of CD from SLE gastrointestinal involvement may be difficult. In fact, cases with inflammatory bowel diseases like CD could show similar clinical signs and symptoms to SLE, and in some cases of CD might fulfill some of the classifications of criteria for SLE. With reference to the literature [10], we listed the following differences between lupus-like Crohn’s from lupus enteritis (Table 1).
Table 1
The Differences between Lupus-like Crohn’s disease and Lupus Enteritis
 
Lupus-like Crohn’s disease
Lupus Enteritis
Clinical Presentation
No specific (abdominal pain, diarrhea)
No specific (abdominal pain, nausea and vomiting)
Abdominal CT scan
Comb’s sign, Segmental bowel stenosis
Comb’s sign, Target sign, Pseudoobstruction, Segmental bowel dilatation
Endoscopy
Cobblestone changes, Segmental and jumping lesions
Multiple round- or oval-shaped discrete ulcers.
Therapy
5-ASA, Corticosteroids, Immunosuppressants, Biological agents
Corticosteroids, Immunosuppressants,
Steroids are considered to be first-line therapy for lupus enteritis. Depending on the clinical state or other organ involvement, steroid administration may be intravenous or oral, preferably in the case of a severe lupus burst, as tissue edema caused by enteritis may reduce drug absorption [11]. Hydroxychloroquine, azathioprine, mycophenolate mofetil could be considered for long-term maintenance treatment, although it is unclear whether recurrence can be prevented.
Here, we report a case of lupus enteritis masquerading as CD which indicated us there are some similar points between lupus enteritis and CD. Firstly, “comb’s sign” can be shown in CT of lupus enteritis or CD. Secondly, ganglion cell is not specific for the CD which can be seen in lupus enteritis. Lastly, the two diseases have similar clinical symptoms including abdominal pain and diarrhea. The endoscopic appearance of lupus enteritis is nonspecific, on the basis of our case, the features of lupus enteritis can be described as spacious, clean and no moss ulcers which discontinuous involved all gastrointestinal tract. More research and cases are needed to further identify the incidence, clinical manifestations, imaging characteristics and endoscopic appearance of lupus enteritis.

Acknowledgments

This work was partly supported by Dr. Chuan-Ying Li, Hang-Cheng Zhou from the Department of Pathology of the Anhui Provincial Hospital. They performed the histological and pathological diagnostic investigations.
All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Oral informed consent was obtained from the patients for publication of this case report and any accompanying images.
During lifetime, patients consented orally to the use of their history and all the related images and information for scientific purposes. After the patients’ death the patients’ next of kin gave written consent for the publication of the cases.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet. 2014;384(9957):1878–88.CrossRef Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet. 2014;384(9957):1878–88.CrossRef
2.
Zurück zum Zitat Assche GV, Dignass A, Panes J, et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohn's Colitis. 2010;4:7–27.CrossRef Assche GV, Dignass A, Panes J, et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohn's Colitis. 2010;4:7–27.CrossRef
3.
Zurück zum Zitat Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.CrossRef Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.CrossRef
4.
Zurück zum Zitat Kawalec P, Mikrut A, Wiśniewska N, Pilc A. Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis. Arch Med Sci. 2013;9(5):765–79.CrossRef Kawalec P, Mikrut A, Wiśniewska N, Pilc A. Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis. Arch Med Sci. 2013;9(5):765–79.CrossRef
5.
Zurück zum Zitat Minordi LM, Vecchioli A, Guidi L, Poloni G, Fedeli G, Bonomo L. CT findings and clinical activity in Crohn's disease. Clin Imaging. 2009;33(2):123–9.CrossRef Minordi LM, Vecchioli A, Guidi L, Poloni G, Fedeli G, Bonomo L. CT findings and clinical activity in Crohn's disease. Clin Imaging. 2009;33(2):123–9.CrossRef
6.
Zurück zum Zitat Tian XP, Zhang X. Gastrointestinal involvement in systemic lupus erythematosus: insight into pathogenesis, diagnosis and treatment. World J Gastroenterol. 2010;16(24):2971–7.CrossRef Tian XP, Zhang X. Gastrointestinal involvement in systemic lupus erythematosus: insight into pathogenesis, diagnosis and treatment. World J Gastroenterol. 2010;16(24):2971–7.CrossRef
7.
Zurück zum Zitat Janssens P, Arnaud L, Galicier L, et al. Lupus enteritis: from clinical findings to therapeutic management. Orphanet J Rare Dis. 2013;8:67.CrossRef Janssens P, Arnaud L, Galicier L, et al. Lupus enteritis: from clinical findings to therapeutic management. Orphanet J Rare Dis. 2013;8:67.CrossRef
8.
Zurück zum Zitat Murosaki T, Nagashima T, Matsumoto K, Minota S. Marked Colonic Wall thickening in lupus enteritis. Intern Med. 2012;51:1451.CrossRef Murosaki T, Nagashima T, Matsumoto K, Minota S. Marked Colonic Wall thickening in lupus enteritis. Intern Med. 2012;51:1451.CrossRef
9.
Zurück zum Zitat Oshimo Y, Harada W, Kariya K. A case of elderly man with systemic lupus erythematosus (SLE) associated with paralytic ileus and fistula formation. Nihon Shokakibyo Gakkai Zasshi. 1999;96(4):413–7.PubMed Oshimo Y, Harada W, Kariya K. A case of elderly man with systemic lupus erythematosus (SLE) associated with paralytic ileus and fistula formation. Nihon Shokakibyo Gakkai Zasshi. 1999;96(4):413–7.PubMed
10.
Zurück zum Zitat Katsanos KH, Voulgari PV, Tsianos EV. Inflammatory bowel disease and lupus: a systematic review of the literature. J Crohns Colitis. 2012;6(7):735–42.CrossRef Katsanos KH, Voulgari PV, Tsianos EV. Inflammatory bowel disease and lupus: a systematic review of the literature. J Crohns Colitis. 2012;6(7):735–42.CrossRef
11.
Zurück zum Zitat Franchin G, Diamond B. Pulse steroids: how much is enough? Autoimmun Rev. 2006;5(2):111–3.CrossRef Franchin G, Diamond B. Pulse steroids: how much is enough? Autoimmun Rev. 2006;5(2):111–3.CrossRef
Metadaten
Titel
Lupus enteritis masquerading as Crohn’s disease
verfasst von
Xiu-Li Zhu
Xue-Mei Xu
Si Chen
Qiao-Min Wang
Kai-Guang Zhang
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
BMC Gastroenterology / Ausgabe 1/2019
Elektronische ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-019-1058-1

Weitere Artikel der Ausgabe 1/2019

BMC Gastroenterology 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.